AUS
NZ
UK
CA
USA
IND
Healthcare
Why Did Royal Bank of Canada Lower Adverum Biotechnologies' Price Target?
November 05, 2024 01:20 PM EST| By Team Kalkine MediaHighlights:,Adverum Biotechnologies focuses on gene therapies targeting ocular diseases.,Royal Bank of Canada adjusted Adverum's price target from a higher estimate to a revised figure.,The company maintains a sector rating that aligns with biotechno...
What Could Go Wrong with Immunic’s Latest Phase 3 MS Study?
November 05, 2024 01:15 PM EST| By Team Kalkine MediaHighlights,Immunic progresses Phase 3 Multiple Sclerosis study, following an independent committee's positive feedback.,AbbVie’s recent acquisition showcases growing interest in small-cap biotech developments.,Immunic's Jessica Breu shares insights o...
Could Grey Wolf Animal Health Corp.'s Recent Surge Be Misleading?
November 05, 2024 11:11 AM EST| By Team Kalkine MediaHighlights,Grey Wolf Animal Health,(TSXV:WOLF),has experienced substantial stock price growth in recent months.,Examining financial indicators, particularly return on equity (ROE), provides insights into the company’s financial health.,ROE can reflec...
What Makes Delivra Health’s Video Campaign a Breakthrough in Chronic Pain Advocacy?
November 04, 2024 04:08 PM EST| By Team Kalkine MediaHighlights,Delivra Health Brands launched a new video campaign focused on the daily challenges of chronic pain sufferers.,The campaign offers a humorous take on chronic pain, likening it to an unrelenting background noise.,Created in collaboration wi...
What’s Fueling the Impressive Rise in Vitalhub Corp.'s Stock Value?
November 04, 2024 02:51 PM EST| By Team Kalkine MediaHighlights,Vitalhub stock showed a significant price increase in recent months.,Return on Equity (ROE) provides insight into Vitalhub's effectiveness in managing funds.,Vitalhub's financial growth reflects its approach to enhancing value in the healt...
Could Concentra Group Holdings Be Poised for a Major Breakout?
November 04, 2024 12:51 PM EST| By Team Kalkine MediaHighlights:,Concentra Group Holdings operates in the healthcare sector, providing health solutions and management services.,Recently, the company's target price was adjusted by Royal Bank of Canada, reflecting a revised outlook.,The updated price tar...
Lilly Reports Q3 2024 Financial Results Driven by Strong Product Demand and Revenue Growth
October 30, 2024 09:25 PM EDT| By Team Kalkine MediaHighlights,20% Revenue Surge:,Growth was powered by high-demand products, especially Mounjaro and Zepbound.,Revised Guidance:,2024 revenue estimates raised to between $45.4 billion and $46.0 billion.,New Product Approvals:,U.S. and Japan approvals fo...
What Makes InnoCan Pharma Stand Out Among TSX Penny Stocks?
October 30, 2024 03:20 PM EDT| By Team Kalkine MediaHighlights,InnoCan Pharma Corporation specializes in drug delivery platforms combining cannabidiol (CBD) with pharmaceutical ingredients.,The company’s liposomal-CBD technology focuses on animal pain relief, gaining positive attention from regulatory...
What Does a Sector Perform Rating Mean for Gilead Sciences' Future?
October 29, 2024 01:30 PM EDT| By Team Kalkine MediaHighlights,Gilead Sciences focuses on biopharmaceutical advancements, particularly in antiviral and oncology therapies.,Royal Bank of Canada maintained its "sector perform" rating on Gilead Sciences.,The recent analysis indicates a revised price targ...
How Is Oneview Expanding Its Reach with Baxter in Canada?
October 29, 2024 10:12 AM EDT| By Team Kalkine MediaHighlights,Oneview Healthcare and Baxter International expand their partnership to Canada.,The collaboration enhances patient experience solutions in healthcare settings.,Training and operational readiness are central to the partnership’s implementat...
Could AbbVie’s New Acquisition Revolutionize Alzheimer's Treatment?
October 28, 2024 03:58 PM EDT| By Team Kalkine MediaHighlights:,AbbVie secures Aliada Therapeutics in an all-cash acquisition for expanding its Alzheimer's treatment portfolio.,The acquisition aligns with AbbVie's increased focus on neuroscience, particularly in response to Humira's slowing demand.,Al...
Is Royal Bank of Canada Signaling a Shift in Universal Health Services' Future?
October 28, 2024 01:31 PM EDT| By Team Kalkine MediaHighlights:,Universal Health Services operates in the health services sector, catering to a wide range of healthcare needs.,Recent analyst activity includes Royal Bank of Canada adjusting its target price from $222 to $211.,The stock maintains a "sec...
Is Fennec Pharmaceuticals Building the Perfect Team for Transformation?
October 28, 2024 12:54 PM EDT| By Team Kalkine MediaHighlights,Fennec Pharmaceuticals Inc. expands its executive leadership team with three key appointments.,The company operates within the pharmaceutical sector, focusing on developing innovative therapies.,Fennec Pharmaceuticals Inc. shares currently...
Is Crescita Therapeutics Overpriced for Future Shareholder Rewards?
October 25, 2024 06:44 PM EDT| By Team Kalkine MediaHighlights,Crescita Therapeutics Inc. maintains a notable position in Canada’s Pharmaceuticals industry with a price-to-sales ratio around 0.7x.,The Pharmaceuticals industry in Canada commonly sees a price-to-sales ratio near 1x, providing context fo...
Is BluSky Carbon on the Brink of Transforming Biochar Production?
October 25, 2024 02:48 PM EDT| By Team Kalkine MediaHighlights,Acasti Pharma to rebrand as Grace Therapeutics, effective soon.,Grace Therapeutics was initially behind GTx-104 before merging with Acasti.,New trading symbol "GRCE" set for Nasdaq listing from October 28, 2024.,Acasti Pharma, recognized f...
Could Rakovina Therapeutics Redefine Cancer Treatment with New Findings?
October 25, 2024 01:55 PM EDT| By Team Kalkine MediaHighlights,Rakovina Therapeutics,(TSXV:RKV),showcased its novel kt-3000 series in cancer research at the EORTC-NCI-AARC Symposium in Barcelona.,The kt-3000 compounds act as bifunctional inhibitors targeting both PARP and HDAC enzymes, showing enhance...
Is Fierce Competition Slowing Edwards Lifesciences’ Growth?
October 24, 2024 05:34 PM EDT| By Team Kalkine MediaHighlights,Edwards Lifesciences faces slowing demand for heart devices and competition in the artificial heart valve sector.,The company posted third-quarter revenues lower than Wall Street's estimates despite growth in transcatheter aortic valve rep...
Can WELL Health Technologies Corp. Reshape the Future of Digital Healthcare?
October 24, 2024 03:04 PM EDT| By Team Kalkine MediaHighlights,WELL Health Technologies operates in the digital health sector.,Fiscal Third-Quarter 2024 results will be released on November 7.,Shares are currently trading at $4.65 on the TSX.,WELL Health Technologies Corp., known for its digital healt...
What Is Ventripoint Diagnostics New CE Certification?
October 24, 2024 02:11 PM EDT| By Team Kalkine MediaHighlights,Ventripoint Diagnostics receives CE certification .,The AI healthcare solution offers automated cardiac image processing.,Certification supports commercialization efforts across the European Union.,Ventripoint Diagnostics,(TSXV:VPT),, an a...
Is Securing a Bargain on Cresco Labs Inc. Now Out of Reach?
October 24, 2024 02:06 PM EDT| By Team Kalkine MediaHighlights,Cresco Labs Inc. operates within the Pharmaceuticals industry in Canada.,The company's current price-to-sales ratio is near the sector average.,Potential deviations in valuation metrics may arise without clear underlying reasons.,Cresco La...
